ELOX - Eloxx Pharmaceuticals Inc
N/A
0 0%
Share volume: 59,391
Last Updated: Fri 30 Aug 2024 11:00:18 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
23%
Profitability
25%
Dept financing
11%
Liquidity
50%
Performance
17%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-54.41%
Return on assets
-18.01%
Return on sales
0%
Return on invested capital
107.25%
Total debt ratio
37.83%
Debt ratio change over timeo
-1.82%
Current Ratio
5%
Quick Ratio
0%
Cash Position Ratio
3.39%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-33.15%
Return on assets
-19.09%
Return on sales
0%
Return on invested capital
106.28%
Total debt ratio
40.43%
Debt ratio change over timeo
-0.68%
Current Ratio
4.82%
Quick Ratio
0%
Cash Position Ratio
2.24%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-38.87%
Return on assets
-19%
Return on sales
0%
Return on invested capital
80.33%
Total debt ratio
49.17%
Debt ratio change over time
-0.55%
Current Ratio
3.62%
Quick Ratio
0%
Cash Position Ratio
2.82%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
4.91%
Return on assets
-90.17%
Return on sales
0%
Return on invested capital
-2.76%
Total debt ratio
-182.12%
Debt ratio change over time
-1.82%
Current Ratio
0.62%
Quick Ratio
0%
Cash Position Ratio
-0.07%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ELOX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -54.41% | 17.45% | 19.89% | 4.69% |
| Return on assets | -18.01% | 3.37% | 11.41% | 3.35% |
| Return on sales | 0% | 23.96% | 42.05% | 25.96% |
| Return on invested capital | 107.25% | 5.2% | -272.99% | 4.37% |
| Profitability | 25% | 45% | 75% | 30% |
| Total debt ratio | 37.83% | 77% | 53.92% | 57.66% |
| Debt ratio change over time | -1.82% | 0.36% | -1.16% | 10.77% |
| Dept financing | 12% | 26% | 18% | 44% |
| Current Ratio | 4.82% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 2.24% | 0.17% | 0.31% | 0.53% |
| Liquididy | 50% | 29% | 24% | 38% |
| Short-term ratios | ELOX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -33.15% | 44.06% | 17.3% | 6.24% |
| Return on assets | -19.09% | 3.88% | 9.33% | 3.22% |
| Return on sales | 0% | 27.04% | 40.02% | 24.93% |
| Return on invested capital | 106.28% | 9.69% | -224.06% | 4.96% |
| Profitability | 25% | 55% | 60% | 29% |
| Total debt ratio | 40.43% | 91.8% | 55.88% | 61.39% |
| Debt ratio change over time | -0.68% | 8.35% | -0.88% | 10.36% |
| Dept financing | 11% | 45% | 15% | 42% |
| Current Ratio | 4.82% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 2.24% | 0.17% | 0.31% | 0.53% |
| Liquididy | 50% | 30% | 28% | 38% |